Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› San Nicolás de los Garza
Clinical trial register · Mexico

Clinical Trials in San Nicolás de los Garza, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in San Nicolás de los Garza

10 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Actopan, Guadalajara, Col Roma Norte, Cuauhtémoc, Tlalpan, Monterrey, San Nicolás de los Garza, Veracruz de Ignacio de La Llave
2026-10-26
Recruiting
Eli Lilly and Company
Phase 3
2,001
Ciudad Madero, Culiacán, Guadalajara, Mexico City, Mérida, Monterrey, San Nicolás de los Garza, Tlalpan
2026-08-26
Recruiting
Eli Lilly and Company
Phase 2
606
Chihuahua City, Mérida, San Nicolás de los Garza, Tlalpan
2026-08-07
Recruiting
Novo Nordisk A/S
Phase 3
80
Coyoacán, Monterrey, San Nicolás de los Garza, Cuauhtémoc, Puebla City
2026-08-04
Recruiting
Novo Nordisk A/S
Phase 3
630
Guadalajara, Col Roma Norte, Distrito Federal, San Nicolás de los Garza, Oaxaca City, Puebla City
2026-04-13
Recruiting
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
NCT07641634Healthy Volunteers, Systemic Sclerosis (SSc), Scleroderma, Systemic, Scleroderma
Prolium Bioscience, Inc
Phase 1/2
44
Chihuahua City, San Nicolás de los Garza
2025-10-27
By invitation
Glycemic Control and the Ask Me 3® Educational Program
NCT07678671Diabetes Mellitus Type 2
Maria Elena Romero Ibarguengoitia
Not applicable
250
San Nicolás de los Garza
2025-06-05
Active, closed
Vicore Pharma AB
Phase 2
378
Mexico City, Monterrey, San Nicolás de los Garza, Oaxaca City
2024-12-09
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc.
Phase 2
213
Monterrey, San Nicolás de los Garza, San Juan del Río, Chihuahua City, Mexico City, Oaxaca City, Puebla City
2024-11-15
Active, closed
PureTech
Phase 2
240
Monterrey, San Nicolás de los Garza, Calpulalpan, Oaxaca City, San Pedro Garza García
2022-07-22
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/san-nicol-s-de-los-garza

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in San Nicolás de los Garza.

How many clinical trials are recruiting in San Nicolás de los Garza?

5 of the 10 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (San Nicolás de los Garza), 10 studies
PhaseStudiesRecruitingShare
Phase 24140%
Phase 34340%
Not applicable1010%
Phase 1/21110%

Most active sponsors

Lead sponsors with the most studies (San Nicolás de los Garza)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S32
Eli Lilly and Company22
Endeavor Biomedicines, Inc.10
Maria Elena Romero Ibarguengoitia10
Prolium Bioscience, Inc11
PureTech10
Vicore Pharma AB10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.